COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 159 filers reported holding COHERUS BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $64 | +18.5% | 31,019 | +92.9% | 0.00% | -50.0% |
| Q4 2023 | $54 | -30.8% | 16,084 | -23.1% | 0.00% | -33.3% |
| Q3 2023 | $78 | -14.3% | 20,914 | -1.5% | 0.00% | -25.0% |
| Q2 2023 | $91 | -37.7% | 21,243 | -0.6% | 0.00% | -33.3% |
| Q1 2023 | $146 | -14.1% | 21,365 | -0.3% | 0.01% | -14.3% |
| Q4 2022 | $170 | -99.9% | 21,440 | -16.9% | 0.01% | -30.0% |
| Q3 2022 | $248,000 | +5.1% | 25,793 | -20.8% | 0.01% | +42.9% |
| Q2 2022 | $236,000 | -43.8% | 32,553 | +0.2% | 0.01% | -30.0% |
| Q1 2022 | $420,000 | -29.4% | 32,498 | -12.9% | 0.01% | -16.7% |
| Q4 2021 | $595,000 | -0.3% | 37,307 | +0.5% | 0.01% | -7.7% |
| Q3 2021 | $597,000 | +11.4% | 37,128 | -4.1% | 0.01% | +30.0% |
| Q2 2021 | $536,000 | +0.2% | 38,728 | +5.7% | 0.01% | -9.1% |
| Q1 2021 | $535,000 | +73.1% | 36,628 | +106.1% | 0.01% | +83.3% |
| Q4 2020 | $309,000 | – | 17,769 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,100,000 | $1,903,000 | 1.75% |
| AlphaCentric Advisors LLC | 1,000,000 | $1,730,000 | 1.27% |
| Tejara Capital Ltd | 1,030,386 | $1,782,568 | 0.65% |
| Rubric Capital Management LP | 10,400,000 | $17,992,000 | 0.47% |
| Birchview Capital, LP | 270,000 | $467,100 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,050,000 | $1,816,500 | 0.18% |
| Bridge City Capital, LLC | 316,009 | $546,696 | 0.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $5,252,413 | 0.16% |
| Tyche Wealth Partners LLC | 215,902 | $373,510 | 0.09% |
| Pennant Investors, LP | 168,100 | $290,813 | 0.08% |